GeneThera Inc. Enters into an exclusive real estate agreement with Cushman & Wakefield related to the ZIDAS project WESTMINSTER, Colo., Oct. 12, 2021 (GLOBE NEWSWIRE) -- GeneThera, Inc. (OTCMKT: GTHR) announced today that it has entered into an exclusive agreement with Cushman & Wakefield (NYSE:CWK) to...

GeneThera Inc. Expands Its Operation in the United Kingdom WESTMINSTER, Colo., May 18, 2021 (GLOBE NEWSWIRE) -- GeneThera is pleased to announce that it has incorporated a subsidiary in the United Kingdom. GeneThera Robotics Ltd, a majority owned subsidiary...

GeneThera enters into a collaboration agreement with an International Construction Advisor Company to build a network of zoonotic diseases laboratory facilities WESTMINSTER, Colo., April 27, 2021 (GLOBE NEWSWIRE) -- GeneThera announced today that it has entered into a partnership agreement with Cumming Corporation, a privately held international project...

GeneThera’s Strategy for the Development of a Global Zoonotic Diseases Surveillance System Using Smart Testing Technology WESTMINSTER, Colo., April 13, 2021 (GLOBE NEWSWIRE) -- We are developing the infrastructure of a global zoonotic infectious diseases “alert shield” (ZIDAS) able to successfully manage and control...

GeneThera Technology Platform for Wastewater Testing: A More Effective Way to Control the COVID-19 Pandemic WESTMINSTER, Colo., April 06, 2021 (GLOBE NEWSWIRE) -- The global COVID-19 pandemic has demonstrated that neither current systems or related technologies are capable of preventing or even...